Original Research
Published on 17 Oct 2023
Causal association of circulating cytokines with sepsis: a Mendelian randomization study
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1281845
- 2,197 views
Type at least 3 characters
1,009 articles
Articles
Original Research
Published on 13 Oct 2023
Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258691
- 1,758 views
Editorial
Published on 10 Oct 2023
Editorial: How to circumvent the tumour-promoting effect of cytokine in tumour therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1298157
- 713 views
Review
Published on 04 Oct 2023
T cell Ca2+ microdomains through the lens of computational modeling
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1235737
- 906 views
Review
Published on 29 Sep 2023
The clinical relevance of OSM in inflammatory diseases: a comprehensive review
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1239732
- 3,147 views
- 1 citation
Original Research
Published on 28 Sep 2023
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1257398
- 1,073 views
Review
Published on 28 Sep 2023
Interleukin 6: at the interface of human health and disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1255533
- 3,390 views
Original Research
Published on 28 Sep 2023
Potential plasma biomarkers at low altitude for prediction of acute mountain sickness
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1237465
- 1,422 views
Original Research
Published on 22 Sep 2023
Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1259007
- 1,493 views
Original Research
Published on 22 Sep 2023
Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1257652
- 2,087 views
Original Research
Published on 20 Sep 2023
Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1261666
- 2,357 views
Methods
Published on 20 Sep 2023
A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1250762
- 1,396 views
Original Research
Published on 18 Sep 2023
Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1216480
- 747 views
Original Research
Published on 11 Sep 2023
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1246777
- 1,012 views
Review
Published on 01 Sep 2023
IL-32 as a potential biomarker and therapeutic target in skin inflammation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1264236
- 1,914 views
Original Research
Published on 01 Sep 2023
Interleukin-36Îł is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1194733
- 1,282 views